How to piss off your liberal friends… and profit from it

Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.

To get the full details on the fake “energy crisis” of America, watch this now

Joseph T. Kennedy net worth and biography

Joseph Kennedy Biography and Net Worth

General Counsel of Amarin

Joseph Kennedy is the executive vice president, general counsel, and secretary of strategic initiatives at Amarin, roles he has held since 2011.

Having spent more than 20 years working with life science companies, Kennedy has experience at all stages of development, from the startup phase to IPOs to product commercialization.

Before Amarin, Kennedy was the vice president and general counsel at Transcept Pharmaceuticals, where he had a key role in negotiating the company’s collaboration with Purdue Pharma and helped obtain FDA approval for the company’s lead product. He previously held the roles of chief legal officer and chief corporate counsel at Eyetech Pharmaceuticals. Kennedy led both Transcept and Eyetech through their public company transitions.

Kennedy also served as vice president and U.S. counsel for corporate business development at Elan Corporation, a biotechnology company headquartered in Dublin, Ireland. He assisted the company in acquiring technologies and managed legal issues related to collaborations. He also participated in a sale of assets, raising over $2 billion in a restructuring.

Additionally, he practiced law at Orrick, Herrington & Sutcliffe LLP.

Kennedy has been honored for his work on numerous occasions, including by Financial Times’ North American Most Innovative Lawyers Awards in 2016, on the Legal500 GC Powerlist: United States 2019, and by the president of Ireland as one of the “Irish Life Science 50,” recognizing Irish-Americans’ contributions to the life science industry.

He earned his bachelor’s degree from Fairfield University and his J.D. from New York Law School.

How do I contact Joseph T. Kennedy?: The corporate mailing address for Mr. Kennedy and other Amarin executives is 77 Sir John Rogerson`s Quay Block C Grand Canal Docklands, Dublin L2, Dublin 2. Amarin can also be reached via phone at (531) 669-9020 and via email at [email protected]. Learn More on Joseph T. Kennedy's contact information.
Has Joseph T. Kennedy been buying or selling shares of Amarin?: Joseph T. Kennedy has not been actively trading shares of Amarin during the last quarter. Most recently, Joseph T. Kennedy sold 54,186 shares of the business's stock in a transaction on Monday, July 1st. The shares were sold at an average price of $19.52, for a transaction totalling $1,057,710.72. Learn More on Joseph T. Kennedy's trading history.
Who are Amarin's active insiders?: Amarin's insider roster includes Michael Kalb (CFO), Joseph Kennedy (General Counsel), Steven Ketchum (Insider), David Stack (Director), and Joseph Zakrzewski (Director). Learn More on Amarin's active insiders.
Are insiders buying or selling shares of Amarin?: During the last twelve months, Amarin insiders bought shares 2 times. They purchased a total of 174,426 shares worth more than $118,124.34. The most recent insider tranaction occured on August, 2nd when CEO Aaron Berg bought 160,000 shares worth more than $102,400.00. Insiders at Amarin own 2.0% of the company. Learn More about insider trades at Amarin.
Information on this page was last updated on 8/2/2024.

Joseph T. Kennedy Insider Trading History at Amarin

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
7/1/2019	Sell	54,186	$19.52	$1,057,710.72
5/31/2019	Sell	27,229	$17.92	$487,943.68
4/30/2019	Sell	27,230	$18.69	$508,928.70
4/1/2019	Sell	54,172	$20.05	$1,086,148.60
2/28/2019	Sell	27,231	$20.72	$564,226.32
1/31/2019	Sell	42,624	$17.49	$745,493.76
1/24/2019	Sell	1,040,194	$17.77	$18,484,247.38
1/11/2019	Sell	3,173	$18.92	$60,033.16
12/31/2018	Sell	26,943	$13.49	$363,461.07
11/30/2018	Sell	23,306	$17.81	$415,079.86
10/31/2018	Sell	23,307	$20.74	$483,387.18
10/1/2018	Sell	50,249	$16.81	$844,685.69
9/24/2018	Sell	1,079,706	$10.56	$11,401,695.36
7/2/2018	Sell	26,942	$3.00	$80,826.00
4/3/2018	Sell	26,942	$2.90	$78,131.80
1/31/2018	Sell	44,857	$3.73	$167,316.61
1/17/2018	Sell	51,106	$4.10	$209,534.60
7/3/2017	Sell	307,911	$4.00	$1,231,644.00

Joseph T. Kennedy Buying and Selling Activity at Amarin

Amarin Company Overview

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Today's Range

Now: $0.47

$0.47

$0.50

50 Day Range

MA: $0.54

$0.46

$0.63

2 Week Range

Now: $0.47

$0.45

$1.37

Volume

2,603,726 shs

Average Volume

1,546,349 shs

Market Capitalization

$192.36 million

P/E Ratio

N/A

Dividend Yield